Literature DB >> 24587981

Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Hairuo Wen1, Judith K Gwathmey2, Lai-Hua Xie1.   

Abstract

Angiotensin II (Ang II), an endogenous peptide hormone, plays critical roles in the pathophysiological modulation of cardiovascular functions. Ang II is the principle effector of the renin-angiotensin system for maintaining homeostasis in the cardiovascular system, as well as a potent stimulator of NAD(P)H oxidase, which is the major source and primary trigger for reactive oxygen species (ROS) generation in various tissues. Recent accumulating evidence has demonstrated the importance of oxidative stress in Ang II-induced heart diseases. Here, we review the recent progress in the study on oxidative stress-mediated effects of Ang II in the cardiovascular system. In particular, the involvement of Ang II-induced ROS generation in arrhythmias, cell death/heart failure, ischemia/reperfusion injury, cardiac hypertrophy and hypertension are discussed. Ca2+/calmodulin-dependent protein kinase II is an important molecule linking Ang II, ROS and cardiovascular pathological conditions.

Entities:  

Keywords:  Angiotensin II; Arrhythmias; Hypertension; Hypertrophy; Ischemia-reperfusion; Mitochondria; Oxidative stress

Year:  2012        PMID: 24587981      PMCID: PMC3936474          DOI: 10.5494/wjh.v2.i4.34

Source DB:  PubMed          Journal:  World J Hypertens        ISSN: 2220-3168


  122 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

Review 2.  Bioactive angiotensin peptides: focus on angiotensin IV.

Authors:  T Mustafa; J H Lee; S Y Chai; A L Albiston; S G McDowall; F A Mendelsohn
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-12       Impact factor: 1.636

3.  Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism.

Authors:  E A Aiello; H E Cingolani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

4.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor.

Authors:  L Daviet; J Y Lehtonen; K Tamura; D P Griese; M Horiuchi; V J Dzau
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  Oxidized CaMKII causes cardiac sinus node dysfunction in mice.

Authors:  Paari Dominic Swaminathan; Anil Purohit; Siddarth Soni; Niels Voigt; Madhu V Singh; Alexey V Glukhov; Zhan Gao; B Julie He; Elizabeth D Luczak; Mei-ling A Joiner; William Kutschke; Jinying Yang; J Kevin Donahue; Robert M Weiss; Isabella M Grumbach; Masahiro Ogawa; Peng-Sheng Chen; Igor Efimov; Dobromir Dobrev; Peter J Mohler; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

Review 7.  Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.

Authors:  M Horiuchi; M Akishita; V J Dzau
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

Review 8.  Angiotensin II and oxidative stress.

Authors:  Hirofumi Hitomi; Hideyasu Kiyomoto; Akira Nishiyama
Journal:  Curr Opin Cardiol       Date:  2007-07       Impact factor: 2.161

9.  Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis.

Authors:  A Ishihata; M Endoh
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  26 in total

1.  S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2.

Authors:  Alice Marino; Takuya Sakamoto; Pablo A Robador; Kengo Tomita; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2017-05-12       Impact factor: 4.030

Review 2.  Essential hypertension and oxidative stress: New insights.

Authors:  Jaime González; Nicolás Valls; Roberto Brito; Ramón Rodrigo
Journal:  World J Cardiol       Date:  2014-06-26

Review 3.  Hypertension and insulin resistance: implications of mitochondrial dysfunction.

Authors:  Walter Manucha; Bob Ritchie; León Ferder
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

4.  Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells.

Authors:  Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Kumuda C Das
Journal:  J Biol Chem       Date:  2015-05-31       Impact factor: 5.157

Review 5.  The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac Remodelling.

Authors:  Michaela Adamcova; Ippei Kawano; Fedor Simko
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  Angiotensin II Induces Differentiation of Human Neuroblastoma Cells by Increasing MAP2 and ROS Levels.

Authors:  Bryan Jael Collazo; Dariana Morales-Vázquez; Jaylene Álvarez-Del Valle; Javier E Sierra-Pagan; Juan Carlos Medina; Jarold Méndez-Álvarez; Yamil Gerena
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-06-14       Impact factor: 1.636

7.  Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Ying Wu; Mei Chen; Min-Na Dong; Yun-Qiao Huang; Chun-Hai Zhang; Yin-Zhong Wang; Jing Xia; Yang Shi; Feng-Mei Xie; Hua Luo; Xin-Yuan Zhao; Wei Wei; Mei-Xian Su
Journal:  Exp Ther Med       Date:  2017-06-09       Impact factor: 2.447

Review 8.  The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion.

Authors:  Simón Quetzalcóatl Rodríguez-Lara; Leonel García-Benavides; Alejandra Guillermina Miranda-Díaz
Journal:  Int J Endocrinol       Date:  2018-04-04       Impact factor: 3.257

Review 9.  The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy.

Authors:  Amaal E Abdulle; Gilles F H Diercks; Martin Feelisch; Douwe J Mulder; Harry van Goor
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

10.  Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses.

Authors:  Xiaowen Shi; Bin Zhang; Zhenliang Chu; Bingjiang Han; Xueping Zhang; Ping Huang; Jibo Han
Journal:  Cardiovasc Ther       Date:  2021-07-01       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.